RECRUITINGINTERVENTIONAL
Miss Rate of Gastric Neoplasms Under Computer-aided Endoscopy
Computer-aided Gastric Lesion Localization and Miss Rate of Gastric Neoplasms: a Tandem, Randomized Controlled Study
About This Trial
This prospective randomized trial compares AI-assisted upper gastrointestinal endoscopy with high definition upper gastrointestinal endoscopy in term of missed rate of gastric neoplasm. The investigators hypothesize the miss rate of high definition upper gastrointestinal endoscopy is higher than AI-assisted upper gastrointestinal endoscopy.
Who May Be Eligible (Plain English)
Who May Qualify:
- Patients aged 40 or older
- Scheduled for elective upper endoscopy
Who Should NOT Join This Trial:
- Pregnant women,
- Inability to provide written willing to sign a consent form
- Prior gastrectomy, and
- Patients deemed unsuitable or high-risk for endoscopy with severe comorbid illnesses
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Patients aged 40 or older
* Scheduled for elective upper endoscopy
Exclusion Criteria:
* Pregnant women,
* Inability to provide written informed consent
* Prior gastrectomy, and
* Patients deemed unsuitable or high-risk for endoscopy with severe comorbid illnesses
Treatments Being Tested
DEVICE
AI-assisted upper gastrointestinal endoscopy
AI-assisted upper gastrointestinal endoscopy
Locations (1)
Queen Mary Hospital, the University of Hong Kong
Hong Kong, Hong Kong